PL3749296T3 - Estry kwasów hydroksybenzoesowych do stosowania w leczeniu rinowirusa - Google Patents

Estry kwasów hydroksybenzoesowych do stosowania w leczeniu rinowirusa

Info

Publication number
PL3749296T3
PL3749296T3 PL19706408T PL19706408T PL3749296T3 PL 3749296 T3 PL3749296 T3 PL 3749296T3 PL 19706408 T PL19706408 T PL 19706408T PL 19706408 T PL19706408 T PL 19706408T PL 3749296 T3 PL3749296 T3 PL 3749296T3
Authority
PL
Poland
Prior art keywords
rhinovirus
hydroxy
esters
treatment
benzoic acids
Prior art date
Application number
PL19706408T
Other languages
English (en)
Inventor
Fredrik Lindberg
Elisabeth Sthengel
Original Assignee
Enzymatica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzymatica Ab filed Critical Enzymatica Ab
Publication of PL3749296T3 publication Critical patent/PL3749296T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL19706408T 2018-02-07 2019-02-07 Estry kwasów hydroksybenzoesowych do stosowania w leczeniu rinowirusa PL3749296T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1801982.8A GB201801982D0 (en) 2018-02-07 2018-02-07 Novel treatments
EP19706408.2A EP3749296B1 (en) 2018-02-07 2019-02-07 Esters of hydroxy-benzoic acids for use in the treatment of rhinovirus
PCT/EP2019/053059 WO2019154937A1 (en) 2018-02-07 2019-02-07 Esters of hydroxy-benzoic acids for use in the treatment of rhinovirus

Publications (1)

Publication Number Publication Date
PL3749296T3 true PL3749296T3 (pl) 2022-03-28

Family

ID=61731283

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19706408T PL3749296T3 (pl) 2018-02-07 2019-02-07 Estry kwasów hydroksybenzoesowych do stosowania w leczeniu rinowirusa

Country Status (9)

Country Link
US (1) US20210213112A1 (pl)
EP (1) EP3749296B1 (pl)
JP (1) JP2021513514A (pl)
CN (1) CN111655251A (pl)
ES (1) ES2900661T3 (pl)
GB (1) GB201801982D0 (pl)
PL (1) PL3749296T3 (pl)
RU (1) RU2020125744A (pl)
WO (1) WO2019154937A1 (pl)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
SE459005B (sv) 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
IL133608A0 (en) * 1997-06-20 2001-04-30 Eggers Sabine A protective composition for inhibiting bacterial, viral and fungal growth on the skin and use thereof
JP2003502071A (ja) 1999-06-18 2003-01-21 ブジャーナソン・ヨーン・ブラーギ 魚類セリンプロティナーゼ及びそれらの薬品及び化粧品への利用
JP4398631B2 (ja) * 2002-07-12 2010-01-13 富山化学工業株式会社 新規なピラジン誘導体またはその塩並びにそれらを含有する抗ウイルス剤
US8044098B2 (en) * 2005-08-02 2011-10-25 Shenghua Guangzhou Pharmaceutical Science & Technology Co., Ltd. Use of hydroxybenzoic acids and their esters and analogues for preventing or treating virus infection
US20070254015A1 (en) * 2006-04-28 2007-11-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Sanitizing surfaces
US20130165470A1 (en) * 2011-12-21 2013-06-27 The Procter & Gamble Company Methods for Detecting and Treating Rhinovirus Infection
GB201405784D0 (en) 2014-03-31 2014-05-14 Enzymatica Ab Novel methods, polypeptides and uses thereof
EP3121272A1 (en) 2015-07-24 2017-01-25 Zymetech ehf. Novel fish trypsin isoforms and their use

Also Published As

Publication number Publication date
GB201801982D0 (en) 2018-03-28
EP3749296A1 (en) 2020-12-16
ES2900661T3 (es) 2022-03-17
WO2019154937A1 (en) 2019-08-15
CN111655251A (zh) 2020-09-11
US20210213112A1 (en) 2021-07-15
RU2020125744A (ru) 2022-02-04
JP2021513514A (ja) 2021-05-27
EP3749296B1 (en) 2021-11-10

Similar Documents

Publication Publication Date Title
IL254288B (en) C22-, c23- and c24-amino-carbonyl-oxy derivatives of bile acids and their use for treating tgr5-mediated diseases
IL252596A0 (en) History of azabicyclooctane as fxr agonists for use in the treatment of liver and gastrointestinal diseases
LT3122878T (lt) Terapija mrnr, skirta akių ligų gydymui
IL279260A (en) KDM1A inhibitors for the treatment of diseases
SMT202100468T1 (it) 24-idrossisteroli sostituiti in posizione 11 per l'uso nel trattamento delle condizioni correlate all'nmda
SG11201607719TA (en) Method and device for the surface treatment of substrates
IL247589A0 (en) Dihydropyridine mgat2 inhibitors for use in the treatment of metabolic disorders
GB201820450D0 (en) Compound and its use for the treatment of alpha1-antitryspin deficiency
SI3592355T1 (sl) KX2-391/KX-01 za uporabo pri zdravljenju aktinične keratoze
ZA202102991B (en) Silicic acids for use in the treatment of periodontitis
GB201706747D0 (en) Method and apparatus for determining the efficacy of statins for treating inflammatory diseases in idividual patients
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
IL281016A (en) Methods to reduce the risk of diabetes in patients treated for diseases related to high cholesterol
IL274747A (en) FXR agonists for the treatment of liver diseases
FI3830067T3 (fi) Menetelmä alkoholien hapettamiseksi
PL3749296T3 (pl) Estry kwasów hydroksybenzoesowych do stosowania w leczeniu rinowirusa
IL251135A (en) A method for the synthesis of hydroxy-triglycerides and their use for disease prevention and treatment
EP3225237A4 (en) Fatty acid amides for the prevention and/or treatment of steatohepatitis
IL251407A0 (en) A multivalent compound for the treatment and prevention of brain damage
ZA201801788B (en) Lysobactin for use in the treatment of bovine mastitis
GB201500555D0 (en) Method and device for the treatment of diseases
HK40044464A (en) R-fadrozole for use in the treatment of aldostonerism
GB201820452D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
GB201820451D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
GB201820455D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency